Should antidiabetic treatment of type 2 diabetes in patients with heart failure differ from that in patients without?

  • Anselm K. Gitt, Martin Halle, Markolf Hanefeld, Monika Kellerer, Nikolaus Marx, Juris J. Meier, Petra-Maria Schumm-Draeger, Peter Bramlage, Diethelm Tschöpe
  • European Journal of Heart Failure, December 2012, Wiley
  • DOI: 10.1093/eurjhf/hfs136

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Peter Bramlage